Global Cystic Fibrosis Diagnostics Market Size, Share, Trends, Analysis and Forecast To 2025

Global Cystic Fibrosis Diagnostics Market Size, Share, Trends, Analysis and Forecast To 2025

Global Cystic Fibrosis Diagnostics market by product type, test type, distribution channels and geographical regions. Key players such as Elucigene, Asper Biogene, ELITechGroup, Natera, Inc., Randox Laboratories Ltd. And Luminex Corporation.

Precision Business Insights (PBI) in its report titled “Global Cystic Fibrosis Diagnostics market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Cystic fibrosis (CF) is a chronic, genetic disease that causes persistent lung infections and limit the ability to breathe over time.
Patients with CF have inherited two copies of the defective CF gene — one copy from each parent. Both parents must have at least one copy of the defective gene. Currently there are approximately 70,000 people who are suffering from cystic fibrosis worldwide.

ASK AN ANALYST:

https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

Market boosts and restraining factors
According to Cystic Fibrosis Foundation, the incidence of these hereditary disorders is constantly mounting. The nonprofit organizations are investing huge amount of funds to find various therapeutics for CF and to support the R &D activities. The major driver for the market is improved diagnostic technologies. Increase in investment and awareness about genetic diseases are aiding in development of diagnostic technologies, which will fuel the market growth.
However, the high cost of the drugs and treatment might hamper the growth of the CF market.

The global Cystic Fibrosis (CF) Diagnostics market is segmented based on the product type, test type, end-users and geographical regions.

REQUEST CUSTOMISATION:
https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-diagnostics-market/#ulp-c654SbFYO64MsOhu

North America holds the lead position in the global cystic fibrosis market
The higher incidence rate of cystic fibrosis is observed in North America. The median age of the person with cystic fibrosis is currently 33.4 years according cystic fibrosis foundation’s national patient registry.
Followed by the North America, Europe too has great numbers of affected population with cystic fibrosis. Out of this affected population, 51.8% were adults and 48.2% were less than 18 years old. Whereas the birth prevalence of CF is higher in United Kingdom, Ireland, Romania, and Bulgaria.
When it comes to the Asian region, the prevalence of cystic fibrosis is seen to be very low. The Middle East and Africa holds the lowest share in the market, especially countries in the African region.

FREE SAMPLE REPORT:
https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-diagnostics-market/#ulp-h4n2eZVGqb32xpPc

Some of the key players in the global Cystic Fibrosis (CF) Diagnostics market include:
• Elucigene
• Asper Biogene
• ELITechGroup
• Natera, Inc.
• Randox Laboratories Ltd.
• Luminex Corporation
• Appolon Bioteck
• Arazy Group
• Illumina Inc.

Notable development in the market
In February 2018, Luminex’s xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil.

Detailed segmentation
By test type
• Antenatal Testing
• Carrier Testing
• Sweat Tests
• CFTR-Related Metabolic Syndrome (CRMS)
• Newborn Screening
• Prenatal Screening

By product type
• Diagnostic Kits
• Reagents
• Others

By end-users
• Hospital
• Diagnostic centers

By geography
• North America
• Europe
• Latin America
• Asia-Pacific
• The Middle East & Africa

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/cystic-fibrosis-cf-diagnostics-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.